CARL
HOLD / NEUTRALNeutralComposite
49.60
Technical
91.10
Fundamental
22.00
Rank
—
Price
18.60
Hurst
0.43
As of
Nov 12, 2026
Daily
Carlsmed, Inc.
HealthcareHealth Information ServicesCarlsmed, Inc. is a medical device firm that develops technology systems for spine fusion procedures, combining surgical planning software powered by machine learning with customized implants tailored to individual patient anatomy. The company's core offering, aprevo, uses algorithmic analysis to guide the design and manufacturing of vertebral interbody implants for spine surgery. Founded in 2018 and headquartered in Carlsbad, California, the company is in the commercial stage of operations.
Market cap
$469.2M
P/E (trailing)
—
P/E (forward)
-10.97
PEG ratio
—
Dividend yield
0.00%
Beta
—
52w range
8.50 – 19.15
Return on equity
-43.95%
Profit margin
-55.82%
Revenue growth
+64.90%
Earnings growth
—
Price history
1Y: 17.12 (+30.6%) · range 8.83–18.60
Cycle position
75/ 100 cycle scoreAPPROACHING EXIT
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 7 · NOT READY · exit proximity 38
Conviction
29/ 100 · maturity 43%
VScore.2217
Buildup.2670
EMA entry setup.327
Fundamentals.1922
Volume profile
POC
11.51
Price vs POC
+48.7%
Overhead supply
5%
Runway
open sky
Value area 9.87–15.29 · 5% of 120d volume overhead · clean runway
Get an AI analyst's read on this ticker.Open the AI analyst
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.900 | Nov 13, 2026 |
Forward returns
Not yet labeled — the study prices these as positions mature.